Change over period
From:
To:
Zoom:
- 1Y
- 3Y
- 5Y
- 10Y
- 15Y
- 20Y
- Max
CEO | Dr. Gregory C. Critchfield M.D., M.S. |
IPO Date | July 15, 2021 |
Location | United States |
Headquarters | 2749 East Parleys Way, Salt Lake City, UT, United States, 84109 |
Employees | 55 |
Sector | Healthcare |
Industry | Diagnostics & research |
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preterm birth, preeclampsia, molecular time-to-birth, predictive analytics, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
NA
NA
NA
NA
NA
StockViz Staff
September 19, 2024
Any question? Send us an email